Halloran is pleased to announce COO, Greg Dombal, will speak at The Conference Forum’s Immuno-Oncology 360°, where he presents on Inspection Readiness.

Register for this event using Halloran’s exclusive discount code (HALL) and receive 25% off the registration price!

The Conference Forum’s Immuno-Oncology 360° is the only conference that combines business and clinical development strategies with scientific updates to prepare the market for accelerating immuno-oncology (IO) clinical trials.

With rapid development of cancer immunotherapy drug development, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce. The science behind immune-based therapies is driving rapid change. Both small and large companies are racing to bring game-changing therapies to the market and in many cases, partnering to maximize on combination therapies. As a result, innovative approaches and developments are also creating increased momentum for investment/business development opportunities.

Designed with input from GSK, Merck, BMS, Novartis, Genentech, Amgen, Eli Lilly, Juno Therapeutics, Leerink Partners, Torreya Partners and MPM Capital, the Immuno-Oncology 360° event will enable attendees to gain a panoramic perspective, including how to optimize clinical strategy, investigate scientific models and approaches to IO, and how to capitalize on market opportunities that will ultimately help revolutionize the way cancer is treated.

Who Should Attend

The program is designed for large pharma, mid-sized biopharma, biotechs and investors seeking to accelerate clinical trials in the emerging immuno-oncology space.

Date: June 29-30, 2015
Place: Faculty House Columbia University
64 Morningside Drive
New York, NY 10027
Price: $1,695. Register using discount code HALL and receive 25% off